• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Responds to Investor Questions Regarding Registration Statement

    11/18/24 8:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email

    OMAHA, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today responds to questions from investors regarding its filing of a registration statement with the SEC.

    On Thursday, November 14th, 2024, the Company filed a shelf registration statement on Form S-3 with the SEC.  On its earnings call, the Company addressed the filing of the S-3.  In response to investor questions, the Company is repeating the information provided by management on the earnings call. 

    In his prepared remarks during the conference call, the Company's CEO, Dayton Judd, stated, "This afternoon, the Company filed a shelf registration statement with the SEC, and I want to take a few minutes to talk through that decision. Close to 50% of eligible exchange-traded companies in the U.S. have an effective shelf registration statement. These are inexpensive to put in place, but they provide a high degree of flexibility if a scenario ever arises where a company wants to raise capital.

    "When declared effective, our shelf will permit sales of stock by either the Company or by Sudbury Capital Fund, our largest shareholder, in a registered offering. You can look at our track record of not diluting shareholders over the years and be confident that if the Company ever decides to sell shares, there will be a really good reason.

    "While neither the Company nor Sudbury has any current plans to sell equity, having an effective shelf registration statement is just good corporate hygiene, and that is why we are putting one in place."

    Later in the call, in response to an investor question about the S-3, Mr. Judd stated, "The likelihood of us needing to raise equity as a company is very slim."

    The full transcript for the earnings call is available on the investor relations page of the Company's website.

    About FitLife Brands

    FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers.  FitLife markets over 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through various retail locations.  FitLife is headquartered in Omaha, Nebraska.  For more information, please visit our website at www.fitlifebrands.com.

    Forward-Looking Statements

    Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Forms 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.



    [email protected]

    Primary Logo

    Get the next $FTLF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:27:11 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3 filed by new insider Pappas Shannon K.

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:26:27 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on FitLife Brands with a new price target

      Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

      3/17/25 8:22:47 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • ROTH MKM initiated coverage on FitLife Brands with a new price target

      ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

      9/3/24 7:48:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:01:06 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Financials

    Live finance-specific insights

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

      Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

      3/27/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care